tykhr
sign in
free sign up
TNF Pharmaceuticals, Inc.
Biotechnology
Healthcare
TNFA
2.00 M shares
NASDAQ US
traded
14 Jan 2025
listed
no
open
1.45
52 week high
10.05
high
1.52
52 week low
1.09
low
1.36
growth
-73.33 %
previous Close
1.45
P/E ratio
-1
market cap
3.13 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-1.93 M
79.83 %
eps
-1.11 %
75.58 %
eps surprise
0.00 %
net profit margin
-192939100.00 %
0.00 %
operating incoming
-1.83 M
45.82 %
net change in cash
656 K
111.46 %
cash on hand
1.19 M
122.44 %
cost of revenue
0.00 %
top